AstraZeneca PLC ADR

AstraZeneca is a Swedish-based pharmaceutical giant dedicated to discovering and developing innovative treatments for conditions like cancer and respiratory diseases. The company gained popularity during the novel COVID-19 pandemic with the development of viral vector vaccines to treat the virus. The company’s most popular product is Tagrisso—a medication used to treat lung carcinomas.

$73.46
(as of Mar 31, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for AstraZeneca PLC ADR

Stock Price
$73.46
Ticker Symbol
AZN
Exchange
NASDAQ

Industry Information for AstraZeneca PLC ADR

Sector
Healthcare
Industry
Drug Manufacturers - General

Company Description for AstraZeneca PLC ADR

Country
USA
Full Time Employees
94,300

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Fundamentals for AstraZeneca PLC ADR

Market Capitalization
$228,773,347,328
EBITDA
$17,567,000,576
Dividends per Share
$3.10
P/E Ratio
32.8
Forward P/E Ratio
16.67
Earnings per Share
$2.25
Earnings per Share Estimate Next Year
Profit Margin
13.01%
Shares Outstanding
3,100,329,984
Percent Owned by Insiders
0.01%
Percent Owned by Institutions
17.52%
52-Week High
52-Week Low

Technical Indicators for AstraZeneca PLC ADR

50-Day Moving Average
200-Day Moving Average
RSI
44.97
1.28

Analyst Ratings for AstraZeneca PLC ADR

Strong Buy
6
Buy
4
Hold
1
Sell
0
Strong Sell
0

News About AstraZeneca PLC ADR

Mar 31, 2025, 7:00 AM EST
Based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death vs. neoadjuvant chemotherapy alone See more.
Mar 31, 2025, 5:31 AM EST
↘️ Nvidia (NVDA): Shares of the artificial-intelligence bellwether fell more than 3% in premarket trading. See more.
Mar 28, 2025, 5:23 PM EST
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. See more.
Mar 27, 2025, 9:30 AM EST
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. See more.